Discover our story - told by trusted sources!

ANTIVIRAL ACTIVITY OF THE EXTRACELLULAR MATRIX MULTI-TISSUE PLATFORM® (MTP) AGAINST FILOVIRUS AND MONKEYPOX VIRUS 
News articles Juliet Hahn News articles Juliet Hahn

ANTIVIRAL ACTIVITY OF THE EXTRACELLULAR MATRIX MULTI-TISSUE PLATFORM® (MTP) AGAINST FILOVIRUS AND MONKEYPOX VIRUS 

As an FDA-cleared product with an established safety record in open wound settings, these in vitro results support further testing in vivo. Furthermore, several tests (including VZV, HSV 1/2, PrV, X-MulLV, and SARS-COV2) were conducted on both MTP Gel and MTP Powder with comparable results, suggesting that further formulation work (e.g., nasal spray, inhalable powder or aerosol, ophthalmic solution) is reasonable.

Read More
Antiviral Action of FetTech’s Multi-Tissue Platform (MTP) Powder and Gel
News articles Juliet Hahn News articles Juliet Hahn

Antiviral Action of FetTech’s Multi-Tissue Platform (MTP) Powder and Gel

Enveloped viruses, or viruses with lipid bilayer membranes on the outer part of the virus, are responsible for some of the most common infections known to mankind. while infections resulting from enveloped viruses are typically less severe than non-enveloped relatives, enveloped viruses are responsible for some of the deadliest epidemics and pandemics in human history.

Read More